In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful ...

INCOG BioPharma Services, a contract development and manufacturing organization (CDMO), has announced strategic expansion ...

The U.S. Food and Drug Administration (FDA) has approved Amgen’s UPLIZNA as the first and only treatment for adults living ...

Neurocrine Biosciences Inc. has appointed Sanjay Keswani, M.D., to the company's executive management team as Chief Medical ...

Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...

Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.